Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00292760
Status:
COMPLETED
Last Update Posted:
2009-12-16
First Post:
2006-02-15
Brief Title:
A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion
Sponsor:
Organization:
Royal Marsden NHS Foundation Trust